Transcriptional control of the RECK metastasis/angiogenesis suppressor gene

被引:65
作者
Sasahara, RM
Brochado, SM
Takahashi, C
Oh, J
Maria-Engler, SS
Granjeiro, JM
Noda, M
Sogayar, MC
机构
[1] Univ Sao Paulo, Inst Quim, BR-05513970 Sao Paulo, Brazil
[2] Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan
来源
CANCER DETECTION AND PREVENTION | 2002年 / 26卷 / 06期
基金
巴西圣保罗研究基金会;
关键词
tumor suppressor gene; metastasis; angiogenesis; transcriptional control; sp1 transcription factor;
D O I
10.1016/S0361-090X(02)00123-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The RECK gene is widely expressed in normal human tissues but is downregulated in tumor cell lines and oncogenically transformed fibroblasts. RECK encodes a membrane-anchored glycoprotein that suppresses tumor invasion and angiogenesis by regulating matrix-metalloproteinases (MMP-2, MMP-9 and MT1-MMP). Understanding of the transcriptional regulation of tumor/metastasis suppressor genes constitutes a potent approach to the molecular basis of malignant transformation. In order to uncover the mechanisms of control of RECK gene expression, the RECK promoter has been cloned and characterized. One of the elements responsible for the Ras-mediated downregulation of mouse RECK gene is the Sp1 site, to which Sp1 and Sp3 factors bind. Other regulatory events, such as DNA methylation of the RECK promoter and histone acetylation/deacetylation have been studied to understand the underlying mechanisms of RECK expression. Understanding of the mechanisms which control RECK gene transcription may lead to the development of new strategies for cancer prevention and treatment. (C) 2002 International Society for Preventive Oncology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:435 / 443
页数:9
相关论文
共 115 条
  • [71] p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
    Milanini, J
    Viñals, F
    Pouysségur, J
    Pagès, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) : 18165 - 18172
  • [72] MILTENBERGER RJ, 1995, CELL GROWTH DIFFER, V6, P549
  • [73] Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO
  • [74] 2-V
  • [75] MURATA Y, 1994, J BIOL CHEM, V269, P20674
  • [76] FLAT REVERTANTS ISOLATED FROM KIRSTEN SARCOMA VIRUS-TRANSFORMED CELLS ARE RESISTANT TO THE ACTION OF SPECIFIC ONCOGENES
    NODA, M
    SELINGER, Z
    SCOLNICK, EM
    BASSIN, RH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18): : 5602 - 5606
  • [77] DETECTION OF GENES WITH A POTENTIAL FOR SUPPRESSING THE TRANSFORMED PHENOTYPE ASSOCIATED WITH ACTIVATED RAS GENES
    NODA, M
    KITAYAMA, H
    MATSUZAKI, T
    SUGIMOTO, Y
    OKAYAMA, H
    BASSIN, RH
    IKAWA, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) : 162 - 166
  • [78] Noti JD, 1996, MOL CELL BIOL, V16, P2940
  • [79] The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
    Oh, J
    Takahashi, R
    Kondo, S
    Mizoguchi, A
    Adachi, E
    Sasahara, RM
    Nishimura, S
    Imamura, Y
    Kitayama, H
    Alexander, DB
    Ide, C
    Horan, TP
    Arakawa, T
    Yoshida, H
    Nishikawa, SI
    Itoh, Y
    Seiki, M
    Itohara, S
    Takahashi, C
    Noda, M
    [J]. CELL, 2001, 107 (06) : 789 - 800
  • [80] p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: Interaction between p53 and Sp1
    Ohlsson, C
    Kley, N
    Werner, H
    LeRoith, D
    [J]. ENDOCRINOLOGY, 1998, 139 (03) : 1101 - 1107